跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 4,961 条关于
“NervGen”
全部
4,961
临床试验
4,830
药物
20
机构
13
资讯
98
去年
NervGen Appoints Randall Kaye as Chief Medical Advisor Following Positive Spinal Cord Injury Trial Results
6个月前
NervGen Pharma Strengthens Leadership Team with Key Regulatory and Patient Advocacy Appointments
去年
NervGen Pharma Highlights Clinical Trial Challenges in Spinal Cord Injury at U2FP Symposium
去年
NervGen Completes Enrollment in Chronic Spinal Cord Injury Trial, Advances to Subacute Phase
2年前
NervGen Pharma Receives Fast Track Designation for NVG-291 in Spinal Cord Injury Treatment
去年
NervGen Nears Enrollment Completion in Spinal Cord Injury Trial of NVG-291
去年
NervGen Pharma to Present Phase 1b/2a Trial of NVG-291 for Spinal Cord Injury at Upcoming Investor Event
10个月前
NervGen Pharma Secures $10 Million Funding to Advance First-in-Class Spinal Cord Injury Therapy NVG-291
去年
Spinal Cord Injury and Ankylosing Spondylitis: Advances in Clinical Trials and Therapies
去年
Spinal Cord Injury Treatment Market Poised for Growth with Emerging Therapies
第 1 页,共 10 页
上一页
下一页